| Literature DB >> 34316303 |
Ashfak H Mandli1, Neelu A Desai2, Rahul S Badheka2, Vrajesh P Udani2.
Abstract
AIMS: We aimed to study the frequency, age, and gender distribution of paroxysmal nonepileptic events (PNEs) in children referred to epilepsy clinic with the diagnosis of epilepsy. We also evaluated the therapeutic implications of correct diagnosis and co-existence of true epilepsy in this population. SETTINGS ANDEntities:
Keywords: Epilepsy mimics; nonepileptic events; paroxysmal; pseudoseizures; psychogenic
Year: 2021 PMID: 34316303 PMCID: PMC8276968 DOI: 10.4103/jpn.JPN_33_20
Source DB: PubMed Journal: J Pediatr Neurosci ISSN: 1817-1745
Distribution of patients by age groups and sex (n = 200)
| Sex of patients | |||
|---|---|---|---|
| Age group | Male | Female | Total |
| A (0 to <5 years) | 52 (66.7%) | 26 (33.3%) | 78 (39%) |
| B (5 to <12 years) | 56 (62.2%) | 34 (37.8%) | 90 (45%) |
| C (≥12 to 18 years) | 19 (59.4%) | 13 (40.6%) | 32 (16%) |
| Total | 127 (63.5%) | 73 (36.5%) | 200 |
Figure 1Final diagnosis of patients seen in epilepsy clinic
Comparison of demographic and clinical characteristics between age groups of patients with PNEs (n = 38)
| Characteristics | Group I (0 to < 5 years of age) | Group II (5 to <12 years of age) | Group III (≥ 12 to 18 years of age) | |
|---|---|---|---|---|
| Male | 12 (54.5%) | 9 (90%) | 3 (50%) | 0.13a |
| Age of onset in months (median, range) | 7(0.23–42) | 108(72–126) | 123(96–144) | <0.0001b |
| Duration of symptoms in months (median, range) | 6(0–36) | 3(0–12) | 42(6–108) | 0.002b |
| Frequency of events | ||||
| Daily | 15 (68.2%) | 6(60%) | 1(16.7%) | 0.11a |
| Weekly | 2 (9.1%) | 0 | 1(16.7%) | |
| Monthly | 2 (9.1%) | 1(10%) | 1(16.7%) | |
| Yearly | 1 (4.5%) | 2(20%) | 3(50%) | |
| Less than 5 events | 2 (9.1%) | 1(10%) | 0 | |
| Duration of events | ||||
| <1 min | 12 (54.5%) | 4(40%) | 2 (33.3%) | 0.58a |
| 1 to 5 min | 6 (27.3%) | 2(20%) | 3(50%) | |
| ≥5 min | 4(18.2%) | 4(40%) | 1(16.7%) | |
| Abnormal EEG | 0 | 1(10%) | 1(16.7%) | 0.34a |
| Concomitant epilepsy | 1(4.5%) | 0 | 2(33.3%) | 0.1a |
| Associated developmental delay | 3(13.6%) | 0 | 0 | 0.72a |
| On treatment with AEDs | 8 (36.4%) | 2(20%) | 3(50%) | 0.45a |
| Duration of treatment with AEDs in months (median, range) | 1.75(0.46–12) | 0.23 | 6(5–12) | 0.02b |
aChi-square test/Fisher’s exact test
bKruskal–Wallis test
Figure 2Frequencies of different types of PNEs
Figure 3Change in treatment after diagnosis of PNE
Follow-up of cases diagnosed as PNEs
| Total no. of cases | Follow-up | Events stopped/reduced/not observed | |
|---|---|---|---|
| Breath holding spells | 5 | 2 | 2 |
| Sleep myoclonus | 7 | 5 | 3 stopped, 2 rare |
| Syncope | 5 | 3 | 3 (1 underwent HUTT ) |
| NEAD | 5 | 3 | 2+1 had reduced freq. on vit. C |
| Movement disorder | 3 | 3 | 1 case of PKD had reduced freq. on CBZ |
| Migraine | 3 | 2 | 0 |
| Tics | 2 | 2 | 0 |
| Benign paroxysmal Vertigo | 2 | 2 | 1 |
| Benign myoclonus of infancy | 1 | 1 | 1 |
| Shuddering attacks | 1 | 1 | 1 |
| Torticollis | 1 | 0 | 0 |
| Parasomnia | 1 | 0 | 0 |
| Cataplexy | 1 | 0 | 0 |
| Self-gratification | 1 | 0 | 0 |
| Total | 38 | 24 | 17 |
NEAD = nonepileptic attack disorders, PKD = paroxysmal kinesiogenic dyskinesia, CBZ = carbamazepine, HUTT = headup tilt table test